Picture of Black Diamond Therapeutics logo

BDTX Black Diamond Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

U.S. RESEARCH ROUNDUP-Eli Lilly, Regeneron Pharmaceuticals, Synopsys

June 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Eli Lilly, Regeneron Pharmaceuticals and Synopsys on
Wednesday. 
    
  HIGHLIGHTS      
      
     * Ansys Inc  ANSS.O : Baird raises target price to $362 from $338
     * Eli Lilly  LLY.N : Cantor Fitzgerald raises target price to $550 from $485
     * Lincoln Electric Holdings, Inc.  LECO.O : Keybanc raises to overweight from sector weight
     * Regeneron Pharmaceuticals Inc  REGN.O : Truist Securities cuts PT to $1045 from $1050
     * Synopsys Inc  SNPS.O : Baird raises target price to $491 from $447
                
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday.
Stock entries are in alphabetical order.   
    
     * Ansys Inc  ANSS.O : Baird raises target price to $362 from $338
     * Biorestorative Therapies Inc  BRTX.O : Maxim Group raises target price to $10 from $6
     * Black Diamond Therapeutics Inc  BDTX.O : Jefferies raises target price to $10 from $5
     * Cadence Design Systems Inc  CDNS.O : Baird raises target price to $253 from $223
     * Caseys General Stores Inc  CASY.O : Jefferies raises target price to $268 from $261
     * Circor International Inc  CIR.N : Stifel raises target price to $51 from $49
     * Coeur Mining  CDE.N : National Bank of Canada initiates with outperform rating; PT $4.25
     * Delek Logistics Partners LP  DKL.N : Citigroup cuts to sell from neutral
     * Delta Air Lines Inc  DAL.N : TD Cowen raises target price to $60 from $54
     * Elf Beauty Inc  ELF.N : Canaccord Genuity raises target price to $125 from $116
     * Eli Lilly  LLY.N : Cantor Fitzgerald raises target price to $550 from $485
     * Extreme Networks Inc  EXTR.O : Oppenheimer initiates with outperform rating; PT $35
     * Hecla Mining Co  HL.N : National Bank of Canada initiates with outperform rating; PT $7.5
     * Interdigital Inc  IDCC.O : Jefferies raises target price to $106 from $90
     * Jerash Holdings (Us) Inc  JRSH.O : D.A. Davidson cuts target price to $6 from $7
     * Lear Corp  LEA.N : Wells Fargo raises target price to $141 from $133
     * Lincoln Electric Holdings, Inc.  LECO.O : Keybanc raises to overweight from sector weight
     * Regeneron Pharmaceuticals Inc  REGN.O : Baird cuts target price to $760 from $800
     * Regeneron Pharmaceuticals Inc  REGN.O : RBC cuts target price to $789 from $816
     * Regeneron Pharmaceuticals Inc  REGN.O : Truist Securities cuts PT to $1045 from $1050
     * Rezolute Inc  RZLT.O : Jefferies cuts target price to $4 from $8
     * Snowflake Inc.  SNOW.N : Piper Sandler raises target price to $210 from $194
     * Synopsys Inc  SNPS.O : Baird raises target price to $491 from $447
     * TD Synnex Corp  SNX.N : Credit Suisse cuts target price to $90 from $106
     * TD Synnex Corp  SNX.N : Raymond James cuts target price to $120 from $125
     * TD Synnex Corp  SNX.N : RBC cuts target price to $98 from $110
     * Uber Technologies Inc  UBER.N : Daiwa Capital Markets raises target price to $51 from $42
     * Walgreens  WBA.O : Evercore ISI cuts target price to $29 from $32
  

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Black Diamond Therapeutics

See all news